IN8bio Presents Positive Data Demonstrating Durable 1-year C

100% of treated leukemia patients achieved durable complete remission at 1-year, including high-risk and relapsed acute myeloid leukemia patients who had previously failed multiple lines of...

Related Keywords

United States , Trishna Goswami , Glenn Schulman , Josephp Mcguirk , Drug Administration , Exchange Commission , Globenewswire Inc , University Of Kansas Cancer Center , Nasdaq , European Hematology Association , Hematology Association , Dose Level , Chief Medical Officer , Speas Professor , Division Director , Hematologic Malignancies , Cellular Therapeutics , Medical Director , Marrow Transplant , Kansas Cancer , Kansas Cancer Center , Private Securities Litigation Reform Act , Quarterly Report ,